Home/Filings/4/0001104659-23-093104
4//SEC Filing

Avista Healthcare Partners, L.P. 4

Accession 0001104659-23-093104

CIK 0001739426other

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 5:04 PM ET

Size

7.9 KB

Accession

0001104659-23-093104

Insider Transaction Report

Form 4
Period: 2023-08-15
Transactions
  • Other

    Ordinary Shares

    2023-08-1523,730,8640 total(indirect: By Avista Capital investment fund)
Transactions
  • Other

    Ordinary Shares

    2023-08-1523,730,8640 total(indirect: By Avista Capital investment fund)
Footnotes (2)
  • [F1]Represents a pro rata in-kind distribution of Ordinary Shares of the Issuer to partners for no consideration and includes subsequent distributions by such partners to their partners and members.
  • [F2]Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Issuer

RVL Pharmaceuticals plc

CIK 0001739426

Entity typeother
IncorporatedBermuda

Related Parties

1
  • filerCIK 0001794239

Filing Metadata

Form type
4
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 5:04 PM ET
Size
7.9 KB